A Monovalent Anti-Human CD28 Domain Antibody Antagonist: Preclinical Efficacy and Safety-Reference-Cited by-同舟云学术

A Monovalent Anti-Human CD28 Domain Antibody Antagonist: Preclinical Efficacy and Safety

Published:2013-09-30 Issue:9 Volume:191 Page:4599-4610
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Suchard Suzanne J.,Davis Patricia M.,Kansal Selena,Stetsko Dawn K.,Brosius Ruth,Tamura James,Schneeweis Lumelle,Bryson James,Salcedo Theodora,Wang Haiqing,Yang Zheng,Fleener Catherine A.,Ignatovich Olga,Plummer Christopher,Grant Steven,Nadler Steven G.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

2. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.;Sperling;J. Immunol.,1996

3. The clinical utility of inhibiting CD28-mediated costimulation

4. Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

5. Differential T Cell Costimulatory Requirements in CD28-Deficient Mice

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

2. T Cell-Dependent Antibody Response Assay: Biology, Methods, and Application;Reference Module in Biomedical Sciences;2024

3. CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant Survival;2023-05-05

4. Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion;Frontiers in Immunology;2023-01-24

5. New immunosuppressive agents in transplantation;La Presse Médicale;2022-12